{"news_desk": "Business", "print_page": "7", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "DealBook Online; Jordanian company Hikma Pharmaceuticals agrees to buy Boehringer Ingelheim's generic drug business in the United States for roughly $2.65 billion in cash and stock.", "type_of_material": "News", "word_count": "468", "lead_paragraph": "Hikma Pharmaceuticals agreed to pay about $2.65 billion in cash and shares for Boehringer Ingelheim\u2019s generic drugs business in the United States.", "pub_date": "2015-07-29T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Hikma Pharmaceuticals to Buy Generic Drug Maker Roxane", "print_headline": "Drug Merger"}, "snippet": "Hikma Pharmaceuticals agreed to pay about $2.65 billion in cash and shares for Boehringer Ingelheim\u2019s generic drugs business in the United States.", "multimedia": [{"height": 126, "url": "images/2015/07/29/business/db-hikma-web1/db-hikma-web1-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/07/29/business/db-hikma-web1/db-hikma-web1-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2015/07/29/business/db-hikma-web1/db-hikma-web1-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2015/07/29/business/db-hikma-web1/db-hikma-web1-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/07/29/business/db-hikma-web1/db-hikma-web1-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/07/29/business/db-hikma-web1/db-hikma-web1-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/07/29/business/dealbook/hikma-pharmaceuticals-to-buy-generic-drug-maker-roxane.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Boehringer Ingelheim GmbH", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Hikma Pharmaceuticals PLC", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Jordan", "name": "glocations"}, {"rank": "4", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Allergan Inc", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Germany", "name": "glocations"}, {"rank": "9", "is_major": "N", "value": "United States", "name": "glocations"}], "blog": [], "_id": "55b75efb38f0d860ec81dcd5", "source": "The New York Times"}